Impact of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on Muscular Fitness and Regeneration After Elective Hip Replacement
Launched by UNIVERSITY HOSPITAL, BONN · Jun 20, 2025
Trial Information
Current as of September 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ability for Rehabilitation
- • Total Hip Arthroplasty Surgery during the last 4 Weeks
- Exclusion Criteria:
- • Sickle Cell Anemia
- • Iatrogenic changes in the vessels of the lower Extremity (e.g. Stents)
- • Open Wounds or Infections of the lower Extremity
About University Hospital, Bonn
The University Hospital Bonn is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution leverages its extensive expertise in various medical disciplines to investigate novel therapies and enhance patient outcomes. With a commitment to ethical standards, patient safety, and rigorous scientific methodologies, the University Hospital Bonn collaborates with multidisciplinary teams and partners to drive forward-thinking solutions in medicine, ultimately contributing to the global body of clinical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bonn, Nrw, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported